NMO-IgG in the diagnosis of neuromyelitis optica.

NMO-IgG in the diagnosis of neuromyelitis optica.

Detalhes bibliográficos
Principais autores:	Jarius, S, Franciotta, D, Bergamaschi, R, Wright, H, Littleton, E, Palace, J, Hohlfeld, R, Vincent, A
Formato:	Journal article
Idioma:	English
Publicado em:	2007

Registros relacionados

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
por: Jarius, S, et al.
Publicado em: (2007)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
por: Littleton, E, et al.
Publicado em: (2006)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
por: Jarius, S, et al.
Publicado em: (2007)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
por: Akman-Demir, G, et al.
Publicado em: (2008)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
por: Tarso Adoni, et al.
Publicado em: (2008-06-01)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
por: Waters, P, et al.
Publicado em: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
por: Paul, F, et al.
Publicado em: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
por: Friedemann Paul, et al.
Publicado em: (2007-04-01)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
por: Min, J, et al.
Publicado em: (2010)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
por: Downer, J, et al.
Publicado em: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
por: Downer, J, et al.
Publicado em: (2012)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
por: Mohammad Hossein Harirchian, et al.
Publicado em: (2015-02-01)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
por: Jacob, A, et al.
Publicado em: (2009)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
por: Jarius, S, et al.
Publicado em: (2007)

Neuromyelitis Optica (NMO) — Study Review
por: Justyna Chojdak-Łukasiewicz
Publicado em: (2021-06-01)

Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
por: Manish Mittal, et al.
Publicado em: (2014-07-01)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado em: (2015-11-01)

Changes in B and T-cell subsets and NMO-IgG/AQP-4 levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica
por: C. de Andrés, et al.
Publicado em: (2015-06-01)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
por: Jarius, S, et al.
Publicado em: (2008)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
por: Jacob, S, et al.
Publicado em: (2007)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
por: Marco A. Lana-Peixoto, et al.
Publicado em: (2011-08-01)

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
por: Waters, P, et al.
Publicado em: (2012)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
por: Saadoun, S, et al.
Publicado em: (2013)

Seroprevalence of Neuromyelitis Optica-IgG of Childhood Compared to Adults
por: J Gordon Millichap
Publicado em: (2008-02-01)

Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis
por: Jarius, S, et al.
Publicado em: (2007)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
por: Narayanan Unni, et al.
Publicado em: (2013-01-01)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
por: Juryńczyk, M, et al.
Publicado em: (2015)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
por: Saadoun, S, et al.
Publicado em: (2013)

Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica.
por: Norio Chihara, et al.
Publicado em: (2013-01-01)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
por: Saadoun, S, et al.
Publicado em: (2013)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
por: Kim, S, et al.
Publicado em: (2011)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
por: Jarius, S, et al.
Publicado em: (2008)

Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
por: Lukmanee Tradtrantip, et al.
Publicado em: (2021-11-01)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
por: Luppe, S, et al.
Publicado em: (2014)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Felix A. Schmidt, et al.
Publicado em: (2020-09-01)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
por: Jarius, S, et al.
Publicado em: (2008)

Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG)
por: Y. Blanco, et al.
Publicado em: (2010-01-01)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
por: Waters, P, et al.
Publicado em: (2008)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
por: Papadopoulos, M, et al.
Publicado em: (2011)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
por: Tianjiao Duan, et al.
Publicado em: (2018-10-01)